Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-center, Open Study Evaluating Efficacy and Safety of XLCART001(CD-19) Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03598179
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:12.110276+00:00
Published At
2019-08-07T00:00:00+00:00
Record Updated At
2019-08-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lymphoma, B-Cell", "Leukemia, B-cell"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-08-07"
protocolSection.identificationModule.nctId
"NCT03598179"
protocolSection.identificationModule.officialTitle
"A Single-center, Open Study Evaluating Efficacy and Safety of XLCART001\uff08CD-19\uff09 Treatment in Relapsed/Refractory/High-risk B-cell Malignancy Subjects"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lymphoma, B-Cell (protocolSection.conditionsModule.conditions)
  • Leukemia, B-cell (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.